Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
Prof. Paul Dendale ,
The effects of supplementation with omega-3 polyunsaturated fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? it depends… B. Rauch and J. Senges Frontiers in Physiology, 2 April 2012, doi: 10.3389/fphys.2012.00057
In this overview, Rauch and collaborators discuss the controversial place of Omega-3 supplementation in the prevention of cardiovascular disease. Due to the mixed results of several studies, its place is not well defined at this moment. After extensively reviewing the literature on this topic, Rauch et al. conclude that the effect of Omega-3 supplementation may depend on the background diet and the pre-existent intake of fish oil. Also, the current treatment for ischemic heart disease probably reduces the positive effects of Omega-3 supplements. The anti-arrhythmic effect is probably greater in ischemia-induced arrhythmias, but is reduced when patients are optimally treated with contemporary medication. This is an interesting article for those of you who want to know the details of this controversial subject.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved